Product Substitution For Excedrin Announced
USProduct Substitution For Excedrin Announced
Recalling Firm: Excedrin, Bristol Myers
Motivo del Retiro / Peligro
TranslatedPoisoning
Descripción del Producto e Identificación
TranslatedProduct Substitution For Excedrin Announced NEWS from CPSC U.S. Consumer Product Safety Commission Office of Information and Public Affairs Washington, DC 20207 FOR IMMEDIATE RELEASE June 7, 1977 Release # 77-059 Product Substitution For Excedrin Announced WASHINGTON, D.C. (June 7) -- Bristol Myers Products, a division of Bristol Myers Company, and the Consumer Product Safety Commission (CPSC) announced today a product substitution of the company's 225 tablet package size and 375 tablet size of Excedrin analgesic tablets which were distributed nationwide prior to April 1977. CPSC testing found same packages for this product failed to comply with Federal regulations requiring that the packages be child-resistant. The product substitution covers warehouse inventories of those major wholesale and retail customers handling approximately 81% of the merchandise. Existing inventories of these packages are being retrieved and replaced by upgraded packages which were tested by Bristol Myers to assure CPSC compliance. The product substitution will involve approximately 150,000 packages and will be completed by the middle of June. These two sizes represent less than 3% of Excedrin analgesic annual unit sales volume. Bristol Myers Products, in addition, has improved its packages for these sizes of Excedrin analgesic products and has expanded its quality control program to reduce the likelihood of similar situations arising in the future. This program is not a substitute for any legal action which may be deemed necessary by CPSC.
Productos Afectados
TranslatedBristol Myers Excedrin
Additional Source Details
| Field | Value |
|---|---|
| U R L | https://www.cpsc.gov/Recalls/1977/Product-Substitution-For-Excedrin-Announced |
| Title | Product Substitution For Excedrin Announced |
| Hazards › Name | Poisoning |
| Products › Name | Bristol Myers Excedrin |
| Products › Type | Medication |
| Products › Category I D | 2043 |
| Recall I D | 3895 |
| Recall Date | 1977-06-07T00:00:00 |
| Description | Product Substitution For Excedrin Announced NEWS from CPSC U.S. Consumer Product Safety Commission Office of Information and Public Affairs Washington, DC 20207 FOR IMMEDIATE RELEASE June 7, 1977 Release # 77-059 Product Substitution For Excedrin Announced WASHINGTON, D.C. (June 7) -- Bristol Myers Products, a division of Bristol Myers Company, and the Consumer Product Safety Commission (CPSC) announced today a product substitution of the company's 225 tablet package size and 375 tablet size of Excedrin analgesic tablets which were distributed nationwide prior to April 1977. CPSC testing found same packages for this product failed to comply with Federal regulations requiring that the packages be child-resistant. The product substitution covers warehouse inventories of those major wholesale and retail customers handling approximately 81% of the merchandise. Existing inventories of these packages are being retrieved and replaced by upgraded packages which were tested by Bristol Myers to assure CPSC compliance. The product substitution will involve approximately 150,000 packages and will be completed by the middle of June. These two sizes represent less than 3% of Excedrin analgesic annual unit sales volume. Bristol Myers Products, in addition, has improved its packages for these sizes of Excedrin analgesic products and has expanded its quality control program to reduce the likelihood of similar situations arising in the future. This program is not a substitute for any legal action which may be deemed necessary by CPSC. |
| Recall Number | 77059 |
| Manufacturers › 1 › Name | Excedrin |
| Manufacturers › 2 › Name | Bristol Myers |
| Last Publish Date | 2015-02-04T00:00:00 |
Consumer Action Protocol: What You Should Do Immediately
Safety StepsCheck the model number, serial number, and date stamp on the rating label on the back or underside of the product.
Immediately discontinue using the product. Unplug electrical items and keep juvenile items out of reach of children.
Under statutory consumer protection rules, consumers are entitled to a full refund, certified replacement, or free repair kit without needing the original sales receipt.
If you suffered an injury, illness, or property damage from this product, file an official incident report with regulatory authorities (CPSC).
Your Legal Rights as a Consumer
Recalls are legally binding corrective safety actions overseen by statutory government bodies. Recalling entities are legally prohibited from charging consumers for official safety remedies. If a retailer or dealership refuses your recall remedy, notify the issuing regulatory agency immediately.
Frequently Asked Questions About This Recall
FAQ GuideQ1:What should I do immediately if I own or bought Product Substitution For Excedrin Announced?
Immediately stop using the product and keep it out of reach of children. Disconnect power if electrical, and do not attempt makeshift home repairs.
Q2:Can I get a full refund or free repair for this recall?
Yes. Recalling manufacturers and retail merchants are required under consumer protection regulations to offer a statutory remedy—typically a full refund, certified repair kit, or replacement unit.
Q3:Do I need my original sales receipt to claim a remedy or refund?
In most recall cases, no receipt is required. Because safety recalls are matters of public health and statutory compliance, retailers and manufacturers routinely issue refunds, store credit, or replacement kits upon presentation of the affected product or lot code.
Q4:Where can I verify official information for this safety alert?
This safety alert is aggregated directly from official regulatory agency records (CPSC). You can click the 'Official Agency Alert' link on this page to view the primary government notice and contact the manufacturer directly.
Revise otros productos en su hogar
Herramientas GratuitasSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Resumen
- Empresa ResponsableExcedrin, Bristol Myers
📢 Compartir advertencia
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Excedrin, Bristol Myers - Product Substitution For Excedrin Announced Check if your household is affected: https://therecallfile.com/es/recalls/product-substitution-for-excedrin-announced/CPSC-77059
Unirse a la lista de alertas
Reciba alertas por correo electrónico cuando se publiquen retiros críticos.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Retiros Relacionados
Health CanadaTransport Canada Recall - 2018088 -
Transport Canada Recall - 2018088 -
Tires
Health CanadaTransport Canada Recall - 2018288 -
Transport Canada Recall - 2018288 -
Airbag
Health CanadaTransport Canada Recall - 2018409 -
Transport Canada Recall - 2018409 -
Airbag